Methodological aspects of creating a soft dosage form with the antiviral effect
DOI:
https://doi.org/10.24959/uekj.21.7Keywords:
methodology; drug; research algorithm; soft dosage formAbstract
Aim. Substantiate the methodology of creating the soft dosage form for the treatment of herpes viral diseases, taking into account the existing requirements for pharmaceutical drug development.
Materials and methods. Drug creating is possible only with a theoretically and experimentally justified process of planning experimental research. To ensure the effectiveness and minimize side effects of the drug under development, it is necessary to take into account all pharmaceutical factors that have affect on the quality of the drug. These are the nature and quantity of the base, physical and chemical properties of active and auxiliary substances, structural and mechanical characteristics and equipment.
The methodological concept of antiviral drug development is based on the implementation of complexes of marketing, pharmaco-technological, physico-chemical and biopharmaceutical research, which ensures compliance of the drug with medical and biological requirements.
Results. It was found that the general algorithm of the methodological approach consists of 3 consecutive stages: information retrieval, research and standardization-pharmacological. Based on the analysis of literature sources and own research, a plan for creating of the soft dosage form with the antiviral effect based on acyclovir and miramistin was developed.
Conclusions. The main methodological aspects of creating the soft dosage form with antiherpetic action, taking into account the requirements for the quality of the drug are shown.
Key words: methodology; drug; research algorithm; soft dosage form
References
Borak, V. P., Romaniuk, L. B., Borak, V. T., Kravets, N. Ya. (2016). Aktualnaia infektologiia, 2, 53 – 58.
Markelova, Ye. V., Saybel, A. V., Krasnitskaia, A. S. (2012). Fundamentalnye issledovaniia, 12, 418 – 425.
Kuskova, T. K., Belova, Ye. G. (2014). Lechashchiy vrach, 5, 5 – 9.
Andrashko, Yu. V., Checherska, T. I., Koval, H. M. (2013). Ukrayinskyi zhurnal dermatolohii, venerolohii, kosmetolohii, 1, 129 – 133.
Zavidniuk, N. H. (2015). Visnyk naukovykh doslidzhen, 4, 14 – 20.
Andreieva, O. H., Rudenko, A. O., Berestova, T. H., Rudenko, N. S. (2011). Profilaktychna medytsyna, 3, 68 – 72.
Veretennikova, M. A. (2014). Farmatsevticheskiye nauki, 8, 1630 – 1634.
Babii, O. V., Vashchenko, K. F. (2014). Ukrainskyi visnyk psykhonevrolohii, 2 (79), 281 – 286.
Bolotnaya, L. A., Shmelkova, Ye. S. (2010). Zdorovye zhenshchiny, 8, 172 – 174.
Hrytsenko, V. I., Kiienko, L. S., Bobrytska, L. O. (2018). Naukovo-tekhnichnyi prohres i optymizatsiia tekhnolohichnykh protsesiv stvorennia likarskykh preparativ: materialy VII naukovo-praktychnoi konferentsii z mizhnarodnoiu uchastiu. (p. 197). Ternopil.
Hrytsenko, V. I., Kiienko, L. S., Bobrytska, L. O. (2018). Mekhanizmy rozvytku patolohichnykh protsesiv i khvorob ta yikhnia farmakolohichna korektsiia: tezy dopovidei I naukovo-praktychnoi internet-konferentsii z mizhnarodnoiu uchastiu. (p. 77). Kharkiv.
Rudenko, V. V. (2012). Farmatsevtychnyi zhurnal, 2, 65 – 68.
Kienko, L., Hrytsenko, V., Iakovlieva, L., Bobrytska L. (2020). Marketing analysis of the assortment of drugs for the treatment of herpes viral diseases at the pharmaceutical market of Ukraine. EUREKA: Health Sciences, 3, 70–76. doi: https://doi.org/10.21303/2504-5679.2020.001285
Downloads
Published
Issue
Section
License
Copyright (c) 2021 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
